Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
3,575
Views
1
CrossRef citations to date
0
Altmetric
Osteoarthritis
Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators
Ervant J. Maksabedian Hernandeza Amgen Inc., Thousand Oaks, CA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1945-3061
Marlon Grafb PRECISIONheor, Los Angeles, CA, USA
, Alexandria Portellib PRECISIONheor, Los Angeles, CA, USA
& Jason Shafrinb PRECISIONheor, Los Angeles, CA, USA
Pages 1118-1126
|
Received 06 Jun 2022, Accepted 11 Aug 2022, Published online: 28 Sep 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.